Journal of Veterinary Medical Science
Online ISSN : 1347-7439
Print ISSN : 0916-7250
ISSN-L : 0916-7250
A pilot study investigating renal biomarkers in dogs with pulmonary hypertension: a comparison between cystatin-C, symmetric dimethylarginine, and creatinine
Zi Ping LEONG
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: 25-0034

Details
Abstract

Pulmonary hypertension (PH) can affect renal function, yet renal dysfunction in canine PH is relatively underexplored. Cystatin C (CYS-C), a useful marker for evaluating renal function in humans with PH, has not been studied in dogs. This study aimed to compare seventeen dogs with PH to a control group, evaluating the relationship between PH and renal parameters such as symmetric dimethylarginine (SDMA), creatinine, and CYS-C. The mean tricuspid regurgitation maximal velocity (TRmax) and systolic pulmonary arterial pressure (SPAP) in dogs with PH was 4.24 m/sec and 74.48 mmHg, respectively. Dogs with PH exhibited significantly higher SDMA (15.47 μg/dL vs. 10.55 μg/dL) and CYS-C (1.36 mg/L vs. 0.88 mg/L) compared to controls. SDMA showed moderate positive correlations with SPAP (r=0.682) and TRmax (r=0.662), and a negative moderate correlation with mean arterial pressure (r=–0.590). CYS-C moderately correlated with SPAP (r=0.529), TRmax (r=0.485), heart rate (r=0.506), and body weight (r=0.691). Creatinine did not vary significantly between PH group (122.21 μmol/L) and controls (93.70 μmol/L), nor did it correlate with any parameters. Multivariate analysis revealed that CYS-C was significantly influenced by PH severity, while SDMA and creatinine were not. These findings suggest that renal dysfunction is prevalent in dogs with PH. CYS-C may be a more sensitive marker for detecting early renal changes linked to PH severity, while SDMA appears to be more specific to true renal dysfunction and creatinine was the least informative biomarker.

Content from these authors
© 2025 by the Japanese Society of Veterinary Science

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top